HPLC measurement of ocular carotenoid levels in human donor eyes in the lutein supplementation era

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 2, 2007, Pages 543-549

  Bhosale, Prakash ^a   Da, You Zhao ^a   Bernstein, Paul S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' OXOLUTEIN; CAROTENOID; MESO ZEAXANTHIN; UNCLASSIFIED DRUG; XANTHOPHYLL; ZEAXANTHIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANALYTIC METHOD; ARTICLE; CHILD; EYE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LENS; MASS SPECTROMETRY; ORGAN DONOR; PRIORITY JOURNAL; RETINA; RETINA MACULA LUTEA; SUPPLEMENTATION; CHEMISTRY; DIET SUPPLEMENTATION; DONOR; FEMALE; MALE; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIETARY SUPPLEMENTS; FEMALE; HUMANS; LENS, CRYSTALLINE; LUTEIN; MACULA LUTEA; MALE; MIDDLE AGED; RETINA; TISSUE DONORS; XANTHOPHYLLS;

EID: 33847750297     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0558     Document Type: Article

References (44)

1. Schmidt-Erfurth U. Nutrition and retina. Dev Ophthalmol. 2005;38:120-147.
2. West AL, Oren GA, Moroi SE. Evidence for the use of nutritional supplements and herbal medicines in common eye diseases. Am J Ophthalmol. 2006;141:157-166.
3. Hogg R, Chakravarthy U. AMD and micronutrient antioxidants. Curr Eye Res. 2004;29:387-401.
4. Bressler NM, Bressler SB, Congdon NG, et al. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol. 2003;121:621-624.
5. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-1436.
6. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr. 2003;23:171-201.
7. Alves-Rodrigues A, Shao A. The science behind lutein. Toxicol Lett. 2004;150:57-83.
8. Zhao DY, Bhosale P, Bernstein PS. Carotenoids and ocular health. Curr Topics Nutraceutical Res. 2006;4:53-68.
9. Bernstein PS, Khachik F, Carvalho LS, Muir GJ, Zhao DY, Katz NB. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res. 2001;72:215-223.
10. Handelman GJ, Dratz EA, Reay CC, van Kuijk FJGM. Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci. 1988;29:850-855.
11. Bone RA, Landrum JT, Fernandez L, Tarsis SL. Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci. 1988;29:843-849.
12. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration: Eye Disease Case-Control Study Group. JAMA. 1994;272:1413-1420.
13. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol. 1993;111:104-109.
14. Gale CR, Hall NF, Phillips DI, Martyn CN. Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2003;44:2461-2465.
15. Bone RA, Landrum JT, Guerra LH, Ruiz CA. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr. 2003;133:992-998.
16. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration, the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 2004;75:216-230.
17. Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE. A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res. 1997;65:57-62.
18. Hammond BR Jr, Johnson EJ, Russell RM, et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci. 1997;38:1795-1801.
19. Koh HH, Murray IJ, Nolan D, Carden D, Feather J, Beatty S. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res. 2004;79:21-27.
20. Duncan JL, Aleman TS, Gardner LM, et al. Macular pigment and lutein supplementation in choroideremia. Exp Eye Res. 2002;74:371-381.
21. Bernstein PS, Zhao DY, Sharifzadeh M, Ermakov TV, Gellermann W. Resonance Raman measurement of macular carotenoids in the living human eye. Arch Biochem Biophys. 2004;430:163-169.
22. Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci. 2000;41:3322-3326.
23. Franciose JL, Askew WE, Lang JC, Bernstein PS. Serum and macular responses to antioxidant supplementation versus a carotenoid-rich dietary intervention in the elderly. Curr Topics Nutraceutical Res. 2006;4:69-76.
24. Snodderly DM, Mares JA, Wooten BR, et al. Macular pigment measurement by heterochromatic flicker photometry in older subjects: the Carotenoids and Age-Related Eye Disease Study. Invest Ophthalmol Vis Sci. 2004;45:531-538.
25. Smith RT, Koniarek JP, Chan J, Nagasaki T, Sparrow JR, Langton K. Autofluorescence characteristics of normal foveas and reconstruction of foveal autofluorescence from limited data subsets. Invest Ophthalmol Vis Sci. 2005;46:2940-2946.
26. Bone RA, Landrum JT. Heterochromatic flicker photometry. Arch Biochem Biophys. 2004;430:137-142.
27. Wooten BR, Hammond BR Jr. Spectral absorbance and spatial distribution of macular pigment using heterochromatic flicker photometry. Optom Vis Sci. 2005;82:378-386.
28. Trieschmann M, Spital G, Lommatzsch A, et al. Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch Clin Exp Ophthalmol. 2003;241:1006-1012.
29. Delori FC. Autofluorescence method to measure macular pigment optical densities fluorometry and autofluorescence imaging. Arch Biochem Biophys. 2004;430:156-162.
30. Khachik F, de Moura FF, Zhao DY, Aebischer CP, Bernstein PS. Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models. Invest Ophthalmol Vis Sci. 2002;43:3383-3392.
31. Bone RA, Landrum JT, Friedes LM, et al. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res. 1997;64:211-218.
32. Bernstein PS, Yoshida MD, Katz NB, McClane RW, Gellermann W. Raman detection of macular carotenoid pigments in intact human retina. Invest Ophthalmol Vis Sci. 1998;39:2003-2011.
33. Snodderly DM, Handelman GJ, Adler AJ. Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci. 1991;32:268-279.
34. Handelman GJ, Snodderly DM, Krinsky NI, Russett MD, Adler AJ. Biological control of primate macular pigment: biochemical and densitometric studies. Invest Ophthalmol Vis Sci. 1991;32:257-267.
35. Bhosale P, Zhao DY, Serban B, Bernstein PS. Identification of 3-methoxyzeaxanthin as a novel age-related carotenoid metabolite in the human macula. Invest Ophthalmol Vis Sci. In press.
36. Bhosale P, Bernstein PS. Quantitative measurement of 3′-oxolutein from human retina by normal-phase high-performance liquid chromatography coupled to atmospheric pressure chemical ionization mass spectrometry. Anal Biochem. 2005;345:296-301.
37. Berendschot TT, Broekmans WM, Klopping-Ketelaars IA, et al. Lens aging in relation to nutritional determinants and possible risk factors for age-related cataract. Arch Ophthalmol. 2002;120:1732-1737.
38. Meyer CH, Sekundo W. Nutritional supplementation to prevent cataract formation. Dev Ophthalmol. 2005;38:103-119.
39. Neelam K, O'Gorman N, Nolan J, et al. Measurement of macular pigment: Raman spectroscopy versus heterochromatic flicker photometry. Invest Ophthalmol Vis Sci. 2005;46:1023-1032.
40. Wooten BR, Hammond BR Jr. Spectral absorbance and spatial distribution of macular pigment using heterochromatic flicker photometry. Optom Vis Sci. 2005;82:378-386.
41. Sharifzadeh M, Bernstein PS, Gellermann W. Non-mydriatic fluorescence-based imaging of human macular pigment distributions. J Opt Soc Am A. 2006;23:2373-2387.
42. Berendschot TT, van Norren D. Objective determination of the macular pigment optical density using fundus reflectance spectroscopy. Arch Biochem Biophys. 2004;430:149-155.
43. Gellermann W, Ermakov IV, Ermakova MR, McClane RW, Zhao DY, Bernstein PS. In vivo resonant Raman measurement of macular carotenoid pigments in the young and the aging human retina. J Opt Soc Am A. 2002;19:1172-1186.
44. Bhosale P, Larson AJ, Frederick JM, Southwick K, Thulin CD, Bernstein PS. Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem. 2004;279:49447-49454.